Early Access to Medicines Scheme in Kuwait

About Early Access to Medicines Scheme

UK MHRA's pathway for early access to promising unlicensed medicines.

How Early Access to Medicines Scheme works in Kuwait

Kuwait's Ministry of Health operates a Personal Import pathway for specialty drugs not registered locally, typically through a hospital pharmacy with physician attestation.

Patients in Kuwait seeking access under Early Access to Medicines Scheme typically follow this flow: a licensed physician in Kuwait issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Kuwait

• Physician prescription and clinical-justification letter.
• Patient identification and consent.
• Country-specific NPP/personal-import form.
• Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Early Access to Medicines Scheme in Kuwait